Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04954833 · ClinicalTrials.gov registry record
Evaluating Visual Acuity and Initial Fit Performance of Two Soft Contact Lenses
A clinical trial, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- 60
- Enrollment target
NCT04954833 is a clinical trial that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 60 participants.
The verdict
NCT04954833 has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is a multi-center, randomized, controlled, double-masked, 2x2 cross-over, non-dispensing study to compare visual acuity and lens fit performance.
Interventions
- DEVICE EMO-200
- DEVICE EMO-118
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2021-06-14 |
| Est. Completion | 2021-08-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04954833
The ClinicalTrials.gov registry entry for NCT04954833 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johnson & Johnson Vision Care, which has 142 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EMO-200 is the first listed.
NCT04954833 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04954833 about?
NCT04954833 is a clinical study titled "Evaluating Visual Acuity and Initial Fit Performance of Two Soft Contact Lenses". This is a multi-center, randomized, controlled, double-masked, 2x2 cross-over, non-dispensing study to compare visual acuity and lens fit performance.
What is the current status of trial NCT04954833?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2021-06-14. Estimated completion is 2021-08-16.
What interventions are being tested in trial NCT04954833?
The interventions under investigation include: EMO-200 (DEVICE), EMO-118 (DEVICE).
Who is sponsoring clinical trial NCT04954833?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.